3.22
+0.3(+10.27%)
Currency In USD
| Previous Close | 2.92 |
| Open | 2.94 |
| Day High | 3.37 |
| Day Low | 2.91 |
| 52-Week High | 4.87 |
| 52-Week Low | 2.12 |
| Volume | 22.92M |
| Average Volume | 8.44M |
| Market Cap | 1.65B |
| PE | -40.25 |
| EPS | -0.08 |
| Moving Average 50 Days | 2.8 |
| Moving Average 200 Days | 3.33 |
| Change | 0.3 |
If you invested $1000 in Clover Health Investments, Corp. (CLOV) since IPO date, it would be worth $315.69 as of October 21, 2025 at a share price of $3.22. Whereas If you bought $1000 worth of Clover Health Investments, Corp. (CLOV) shares 3 years ago, it would be worth $2,205.48 as of October 21, 2025 at a share price of $3.22.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
GlobeNewswire Inc.
Oct 15, 2025 12:30 PM GMT
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable ValueJERSEY CITY, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Heal
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
GlobeNewswire Inc.
Oct 14, 2025 12:30 PM GMT
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plansSAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Cor
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
GlobeNewswire Inc.
Oct 09, 2025 8:55 PM GMT
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent of Star ratings WILMINGTON, Del., Oct. 09, 2025